Your browser doesn't support javascript.
loading
Circulating tumor DNA predicts efficacy of a dual AKT/p70S6K inhibitor (LY2780301) plus paclitaxel in metastatic breast cancer: plasma analysis of the TAKTIC phase IB/II study.
Sabatier, Renaud; Vicier, Cécile; Garnier, Séverine; Guille, Arnaud; Carbuccia, Nadine; Isambert, Nicolas; Dalenc, Florence; Robert, Marie; Levy, Christelle; Pakradouni, Jihane; Adelaïde, José; Chaffanet, Max; Sfumato, Patrick; Mamessier, Emilie; Bertucci, François; Goncalves, Anthony.
Afiliação
  • Sabatier R; CRCM-Predictive Oncology Laboratory, Institut Paoli-Calmettes, Inserm, CNRS, Aix-Marseille Université, France.
  • Vicier C; Institut Paoli-Calmettes-Department of Medical Oncology, CRCM, Inserm, CNRS, Aix-Marseille Université, France.
  • Garnier S; Institut Paoli-Calmettes-Department of Medical Oncology, CRCM, Inserm, CNRS, Aix-Marseille Université, France.
  • Guille A; CRCM-Predictive Oncology Laboratory, Institut Paoli-Calmettes, Inserm, CNRS, Aix-Marseille Université, France.
  • Carbuccia N; CRCM-Predictive Oncology Laboratory, Institut Paoli-Calmettes, Inserm, CNRS, Aix-Marseille Université, France.
  • Isambert N; CRCM-Predictive Oncology Laboratory, Institut Paoli-Calmettes, Inserm, CNRS, Aix-Marseille Université, France.
  • Dalenc F; Drug Development Department, Centre Georges François Leclerc, Dijon, France.
  • Robert M; Department of Medical Oncology, Institut Claudius Regaud, CRCT, Inserm, IUCT-Oncopole, Toulouse, France.
  • Levy C; Institut de Cancérologie de l'Ouest-René Gauducheau, Saint-Herblain, France.
  • Pakradouni J; Department of Medical Oncology, Centre François Baclesse, Caen, France.
  • Adelaïde J; Depatment of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
  • Chaffanet M; CRCM-Predictive Oncology Laboratory, Institut Paoli-Calmettes, Inserm, CNRS, Aix-Marseille Université, France.
  • Sfumato P; CRCM-Predictive Oncology Laboratory, Institut Paoli-Calmettes, Inserm, CNRS, Aix-Marseille Université, France.
  • Mamessier E; Depatment of Clinical Research and Innovation, Institut Paoli-Calmettes, Marseille, France.
  • Bertucci F; Institut Paoli-Calmettes-Department of Medical Oncology, CRCM, Inserm, CNRS, Aix-Marseille Université, France.
  • Goncalves A; CRCM-Predictive Oncology Laboratory, Institut Paoli-Calmettes, Inserm, CNRS, Aix-Marseille Université, France.
Mol Oncol ; 16(10): 2057-2070, 2022 05.
Article em En | MEDLINE | ID: mdl-35122700
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / DNA Tumoral Circulante Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article